A report examining the impact of Paxlovid on 13 long Covid patients found mixed results, emphasizing the uncertainty surrounding effective treatments nearly five years into the pandemic.
Alison Cohen, an epidemiologist at UCSF, noted, 'There's been a lot of research, but it continues to be slow going,' highlighting the ongoing struggle to identify effective treatments for long Covid.
The report suggests that while Paxlovid may provide relief for some long Covid patients, its efficacy varies widely, with only five out of nine reporting lasting improvements.
Researchers theorize that lingering virus remnants may cause some long Covid cases, positioning Paxlovid as a potential treatment option that could help eliminate such symptoms.
Collection
[
|
...
]